Open Access
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim
1
,
Helena Kupcova Skalnikova
2
,
Jana Cizkova
2, 3
,
Veronika Cizkova
2, 4
,
Anna Palanova
2
,
Vratislav Horak
2
,
Jakub Mrázek
1
3
Department of Radiobiology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
|
Publication type: Journal Article
Publication date: 2022-02-25
scimago Q1
wos Q2
SJR: 1.032
CiteScore: 6.7
Impact factor: 4.2
ISSN: 14712180
PubMed ID:
35216552
Microbiology (medical)
Microbiology
Abstract
The microbiome alterations are associated with cancer growth and may influence the immune system and response to therapy. Particularly, the gut microbiome has been recently shown to modulate response to melanoma immunotherapy. However, the role of the skin microbiome has not been well explored in the skin tumour microenvironment and the link between the gut microbiome and skin microbiome has not been investigated in melanoma progression. Therefore, the aim of the present study was to examine associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression. Parallel analysis of cutaneous microbiota and faecal microbiota of the same individuals was performed in 8 to 12 weeks old MeLiM piglets. The bacterial composition of samples was analysed by high throughput sequencing of the V4-V5 region of the 16S rRNA gene. A significant difference in microbiome diversity and richness between melanoma tissue and healthy skin and between the faecal microbiome of MeLiM piglets and control piglets were observed. Both Principal Coordinate Analysis and Non-metric multidimensional scaling revealed dissimilarities between different bacterial communities. Linear discriminant analysis effect size at the genus level determined different potential biomarkers in multiple bacterial communities. Lactobacillus, Clostridium sensu stricto 1 and Corynebacterium 1 were the most discriminately higher genera in the healthy skin microbiome, while Fusobacterium, Trueperella, Staphylococcus, Streptococcus and Bacteroides were discriminately abundant in melanoma tissue microbiome. Bacteroides, Fusobacterium and Escherichia-Shigella were associated with the faecal microbiota of MeLiM piglets. Potential functional pathways analysis based on the KEGG database indicated significant differences in the predicted profile metabolisms between the healthy skin microbiome and melanoma tissue microbiome. The faecal microbiome of MeLiM piglets was enriched by genes related to membrane transports pathways allowing for the increase of intestinal permeability and alteration of the intestinal mucosal barrier. The associations between melanoma progression and dysbiosis in the skin microbiome as well as dysbiosis in the gut microbiome were identified. Results provide promising information for further studies on the local skin and gut microbiome involvement in melanoma progression and may support the development of new therapeutic approaches.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
International Journal of Molecular Sciences
5 publications, 6.41%
|
|
|
Microorganisms
5 publications, 6.41%
|
|
|
Frontiers in Oncology
3 publications, 3.85%
|
|
|
Scientific Reports
3 publications, 3.85%
|
|
|
Clinical, Cosmetic and Investigational Dermatology
3 publications, 3.85%
|
|
|
Frontiers in Immunology
3 publications, 3.85%
|
|
|
JDDG - Journal of the German Society of Dermatology
2 publications, 2.56%
|
|
|
Frontiers in Genetics
2 publications, 2.56%
|
|
|
Cancer Immunology, Immunotherapy
2 publications, 2.56%
|
|
|
Journal of Clinical Medicine
1 publication, 1.28%
|
|
|
Journal of Biological Research (Italy)
1 publication, 1.28%
|
|
|
Life
1 publication, 1.28%
|
|
|
Cancers
1 publication, 1.28%
|
|
|
Journal of Functional Foods
1 publication, 1.28%
|
|
|
Journal for ImmunoTherapy of Cancer
1 publication, 1.28%
|
|
|
Microbial Pathogenesis
1 publication, 1.28%
|
|
|
eGastroenterology
1 publication, 1.28%
|
|
|
Frontiers in Microbiology
1 publication, 1.28%
|
|
|
JAMA Dermatology
1 publication, 1.28%
|
|
|
Cureus
1 publication, 1.28%
|
|
|
Environmental Microbiomes
1 publication, 1.28%
|
|
|
Parasitology Research
1 publication, 1.28%
|
|
|
Applied Microbiology and Biotechnology
1 publication, 1.28%
|
|
|
Journal of Personalized Medicine
1 publication, 1.28%
|
|
|
Melanoma Research
1 publication, 1.28%
|
|
|
Current Issues in Molecular Biology
1 publication, 1.28%
|
|
|
Animal Microbiome
1 publication, 1.28%
|
|
|
Cancer immunology research
1 publication, 1.28%
|
|
|
Photochemistry and Photobiology
1 publication, 1.28%
|
|
|
1
2
3
4
5
|
Publishers
|
2
4
6
8
10
12
14
16
18
|
|
|
Springer Nature
18 publications, 23.08%
|
|
|
MDPI
17 publications, 21.79%
|
|
|
Frontiers Media S.A.
10 publications, 12.82%
|
|
|
Wiley
8 publications, 10.26%
|
|
|
Elsevier
5 publications, 6.41%
|
|
|
Taylor & Francis
4 publications, 5.13%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 3.85%
|
|
|
BMJ
2 publications, 2.56%
|
|
|
PAGEPress Publications
1 publication, 1.28%
|
|
|
American Medical Association (AMA)
1 publication, 1.28%
|
|
|
American Association for Cancer Research (AACR)
1 publication, 1.28%
|
|
|
Oriental Scientific Publishing Company
1 publication, 1.28%
|
|
|
American Chemical Society (ACS)
1 publication, 1.28%
|
|
|
The Company of Biologists
1 publication, 1.28%
|
|
|
Oxford University Press
1 publication, 1.28%
|
|
|
Spandidos Publications
1 publication, 1.28%
|
|
|
AME Publishing Company
1 publication, 1.28%
|
|
|
American Physiological Society
1 publication, 1.28%
|
|
|
American Society for Microbiology
1 publication, 1.28%
|
|
|
2
4
6
8
10
12
14
16
18
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
78
Total citations:
78
Citations from 2024:
55
(70.51%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Mekadim C. et al. Dysbiosis of skin microbiome and gut microbiome in melanoma progression // BMC Microbiology. 2022. Vol. 22. No. 1. 63
GOST all authors (up to 50)
Copy
Mekadim C., Skalnikova H. K., Cizkova J., Cizkova V., Palanova A., Horak V., Mrázek J. Dysbiosis of skin microbiome and gut microbiome in melanoma progression // BMC Microbiology. 2022. Vol. 22. No. 1. 63
Cite this
RIS
Copy
TY - JOUR
DO - 10.1186/s12866-022-02458-5
UR - https://doi.org/10.1186/s12866-022-02458-5
TI - Dysbiosis of skin microbiome and gut microbiome in melanoma progression
T2 - BMC Microbiology
AU - Mekadim, Chahrazed
AU - Skalnikova, Helena Kupcova
AU - Cizkova, Jana
AU - Cizkova, Veronika
AU - Palanova, Anna
AU - Horak, Vratislav
AU - Mrázek, Jakub
PY - 2022
DA - 2022/02/25
PB - Springer Nature
IS - 1
VL - 22
PMID - 35216552
SN - 1471-2180
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Mekadim,
author = {Chahrazed Mekadim and Helena Kupcova Skalnikova and Jana Cizkova and Veronika Cizkova and Anna Palanova and Vratislav Horak and Jakub Mrázek},
title = {Dysbiosis of skin microbiome and gut microbiome in melanoma progression},
journal = {BMC Microbiology},
year = {2022},
volume = {22},
publisher = {Springer Nature},
month = {feb},
url = {https://doi.org/10.1186/s12866-022-02458-5},
number = {1},
pages = {63},
doi = {10.1186/s12866-022-02458-5}
}